Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3916 to 3930 of 8933 results

  1. About quality standards

    Our quality standards set out priority areas for quality improvement in health, public health and social care.

  2. Help develop quality standards

    Home Get involved...

  3. Public board meeting agenda and papers: January 2022

    Agenda and papers of the NICE public board meeting on 19 January 2022

  4. Trade union facility time report

    The time and proportion of pay used by trade union representatives to carry out their union role.

  5. Guidance executive

    NICE's guidance executive is made up of executive directors, guidance centre directors and senior team members.

  6. Partnering with us for research - timescales and process

    Home What NICE does Our research work {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1

  7. Stakeholder registration: diagnostic technologies

    How to register with us as a diagnostic technologies stakeholder.

  8. Topic engagement

    Home Get involved Help develop quality standards...

  9. How we develop technology appraisal guidance

    A step-by-step summary about how we develop our technology appraisal guidance.

  10. Taking a proportionate approach to technology appraisals

    Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.

  11. Percutaneous transarterial carotid artery stent placement for asymptomatic extracranial carotid stenosis (HTG704)

    Evidence-based recommendations on percutaneous transarterial carotid artery stent placement for asymptomatic extracranial carotid stenosis. This involves using a wire mesh tube called a stent to widen the narrowed carotid artery.

  12. Transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (HTG691)

    Evidence-based recommendations on transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia. This involves injecting a high-speed jet of water into the prostate to destroy some of the prostate tissue and widen the urethra.

  13. Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes (HTG371)

    Evidence-based recommendations on implantation of a duodenal-jejunal bypass liner for managing type 2 diabetes. This involves attaching a liner as a barrier between food and the upper part of the bowel, with the aim of lowering blood sugar levels.